Remifentanil for fetal immobilization and analgesia during the ex utero intrapartum treatment procedure under combined spinalepidural anaesthesia

Ryan Fink, T. K. Allen, A. S. Habib

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Remifentanil undergoes extensive placental transfer and has been used to provide fetal immobilization and anaesthesia for in utero fetal endoscopic interventions. We report three cases of the ex utero intrapartum treatment performed under neuraxial anaesthesia where the maternal administration of remifentanil was used to provide fetal immobilization and analgesia. Fetal pathology included goiter and arthrogryposis, with one case requiring a tracheostomy. The longest time on placental circulation was 21 min. No clinically significant maternal sedation or respiratory depression was observed. In all cases, remifentanil provided adequate fetal immobilization and obviated the need to administer other analgesics or neuromuscular blocking agents. Remifentanil is a useful adjunct for ex utero fetal procedures.

Original languageEnglish (US)
Pages (from-to)851-855
Number of pages5
JournalBritish Journal of Anaesthesia
Volume106
Issue number6
DOIs
StatePublished - Jun 2011
Externally publishedYes

Fingerprint

Immobilization
Analgesia
Anesthesia
Mothers
Placental Circulation
Arthrogryposis
Neuromuscular Blocking Agents
Tracheostomy
Goiter
Therapeutics
Respiratory Insufficiency
Analgesics
Pathology
remifentanil

Keywords

  • anaesthesia, epidural
  • anaesthesia, spinal
  • remifentanil hydrochloride
  • therapy, fetal

ASJC Scopus subject areas

  • Anesthesiology and Pain Medicine

Cite this

Remifentanil for fetal immobilization and analgesia during the ex utero intrapartum treatment procedure under combined spinalepidural anaesthesia. / Fink, Ryan; Allen, T. K.; Habib, A. S.

In: British Journal of Anaesthesia, Vol. 106, No. 6, 06.2011, p. 851-855.

Research output: Contribution to journalArticle

@article{db9031d427b5478cb214428526502228,
title = "Remifentanil for fetal immobilization and analgesia during the ex utero intrapartum treatment procedure under combined spinalepidural anaesthesia",
abstract = "Remifentanil undergoes extensive placental transfer and has been used to provide fetal immobilization and anaesthesia for in utero fetal endoscopic interventions. We report three cases of the ex utero intrapartum treatment performed under neuraxial anaesthesia where the maternal administration of remifentanil was used to provide fetal immobilization and analgesia. Fetal pathology included goiter and arthrogryposis, with one case requiring a tracheostomy. The longest time on placental circulation was 21 min. No clinically significant maternal sedation or respiratory depression was observed. In all cases, remifentanil provided adequate fetal immobilization and obviated the need to administer other analgesics or neuromuscular blocking agents. Remifentanil is a useful adjunct for ex utero fetal procedures.",
keywords = "anaesthesia, epidural, anaesthesia, spinal, remifentanil hydrochloride, therapy, fetal",
author = "Ryan Fink and Allen, {T. K.} and Habib, {A. S.}",
year = "2011",
month = "6",
doi = "10.1093/bja/aer097",
language = "English (US)",
volume = "106",
pages = "851--855",
journal = "British Journal of Anaesthesia",
issn = "0007-0912",
publisher = "Oxford University Press",
number = "6",

}

TY - JOUR

T1 - Remifentanil for fetal immobilization and analgesia during the ex utero intrapartum treatment procedure under combined spinalepidural anaesthesia

AU - Fink, Ryan

AU - Allen, T. K.

AU - Habib, A. S.

PY - 2011/6

Y1 - 2011/6

N2 - Remifentanil undergoes extensive placental transfer and has been used to provide fetal immobilization and anaesthesia for in utero fetal endoscopic interventions. We report three cases of the ex utero intrapartum treatment performed under neuraxial anaesthesia where the maternal administration of remifentanil was used to provide fetal immobilization and analgesia. Fetal pathology included goiter and arthrogryposis, with one case requiring a tracheostomy. The longest time on placental circulation was 21 min. No clinically significant maternal sedation or respiratory depression was observed. In all cases, remifentanil provided adequate fetal immobilization and obviated the need to administer other analgesics or neuromuscular blocking agents. Remifentanil is a useful adjunct for ex utero fetal procedures.

AB - Remifentanil undergoes extensive placental transfer and has been used to provide fetal immobilization and anaesthesia for in utero fetal endoscopic interventions. We report three cases of the ex utero intrapartum treatment performed under neuraxial anaesthesia where the maternal administration of remifentanil was used to provide fetal immobilization and analgesia. Fetal pathology included goiter and arthrogryposis, with one case requiring a tracheostomy. The longest time on placental circulation was 21 min. No clinically significant maternal sedation or respiratory depression was observed. In all cases, remifentanil provided adequate fetal immobilization and obviated the need to administer other analgesics or neuromuscular blocking agents. Remifentanil is a useful adjunct for ex utero fetal procedures.

KW - anaesthesia, epidural

KW - anaesthesia, spinal

KW - remifentanil hydrochloride

KW - therapy, fetal

UR - http://www.scopus.com/inward/record.url?scp=79957529795&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79957529795&partnerID=8YFLogxK

U2 - 10.1093/bja/aer097

DO - 10.1093/bja/aer097

M3 - Article

VL - 106

SP - 851

EP - 855

JO - British Journal of Anaesthesia

JF - British Journal of Anaesthesia

SN - 0007-0912

IS - 6

ER -